Skip to content

Voyager Therapeutics, Inc.: filings

Every Voyager Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 44 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 2026441230001640266-26-000006
10-Q2026-05-07fiscal Q1 202643880001104659-26-057097
10-K2026-03-09fiscal FY 2025481240001104659-26-025197
10-Q2025-11-10fiscal Q3 2025431260001104659-25-108846
10-Q2025-08-06fiscal Q2 2025431220001558370-25-010511
10-Q2025-05-06fiscal Q1 202543870001558370-25-006484
10-K2025-03-11fiscal FY 2024481220001558370-25-002703
10-Q2024-11-12fiscal Q3 2024441290001558370-24-015304
10-Q2024-08-06fiscal Q2 2024441260001558370-24-011073
10-Q2024-05-13fiscal Q1 202443910001558370-24-007953
10-K2024-02-28fiscal FY 2023461190001558370-24-001988
10-Q2023-11-06fiscal Q3 2023431260001558370-23-017754
10-Q2023-08-03fiscal Q2 2023421220001558370-23-013058
10-Q2023-05-09fiscal Q1 202342870001558370-23-008656
10-K2023-03-07fiscal FY 2022451170001558370-23-002989
10-Q2022-11-08fiscal Q3 2022411210001558370-22-016733
10-Q2022-08-04fiscal Q2 2022391120001558370-22-012267
10-Q2022-05-04fiscal Q1 202239820001558370-22-007065
10-K2022-03-08fiscal FY 2021441140001558370-22-003015
10-Q2021-11-02fiscal Q3 2021411210001558370-21-013999
10-Q2021-08-09fiscal Q2 202136970001558370-21-010878
10-Q2021-05-10fiscal Q1 202136760001558370-21-006582
10-K2021-02-25fiscal FY 2020461180001558370-21-001865
10-Q2020-11-09fiscal Q3 2020411210001558370-20-013395
10-Q2020-08-10fiscal Q2 2020401130001558370-20-010047
10-Q2020-05-06fiscal Q1 202036770001558370-20-005300
10-K2020-03-03fiscal FY 2019421350001558370-20-001974
10-Q2019-11-06fiscal Q3 2019391060001558370-19-010066
10-Q2019-08-09fiscal Q2 2019441220001558370-19-007823
10-Q2019-05-07fiscal Q1 201937770001558370-19-004165
10-K2019-02-26fiscal FY 2018391330001558370-19-001105
10-Q2018-11-07fiscal Q3 201837960001558370-18-008821
10-Q2018-08-07fiscal Q2 201837970001558370-18-006628
10-Q2018-05-10fiscal Q1 201837760001558370-18-004575
10-K2018-03-14fiscal FY 2017371270001558370-18-002038
10-Q2017-11-02fiscal Q3 201733890001558370-17-008016
10-Q2017-08-08fiscal Q2 201733880001558370-17-006208
10-Q2017-05-09fiscal Q1 201731630001558370-17-003998
10-K2017-03-15fiscal FY 2016361200001558370-17-001797
10-Q2016-11-10fiscal Q3 201631850001558370-16-009940
10-Q2016-08-11fiscal Q2 201627720001558370-16-007918
10-Q2016-05-12fiscal Q1 201627560001558370-16-005926
10-K2016-03-17fiscal FY 201530960001558370-16-004222
10-Q2015-12-17fiscal Q3 201528730001558370-15-002867

Inspect the source

Entity
Voyager Therapeutics, Inc. / CIK 0001640266
Captured
2026-09-21T17:21:36.313Z
SEC response SHA-256
8090dbaa25dde9bd5981886fdac01f04bbe6c04ceaca1eba74d87843f38b004e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001640266.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))